Changeflow GovPing Legal Enforcement FR: Justice Department
Favicon for www.federalregister.gov

FR: Justice Department

RSS
Favicon for www.federalregister.gov

DEA: Bulk Manufacturer Controlled Substances Application Pisgah Laboratories Inc

The Drug Enforcement Administration (DEA) has published a notice regarding an application from Pisgah Laboratories Inc. for a bulk manufacturer of controlled substances permit. The notice opens a public comment period for interested parties.

Priority review Notice Pharmaceuticals
Favicon for www.federalregister.gov

Importer of Controlled Substances Application: Lonza Tampa, LLC

The Drug Enforcement Administration (DEA) has published a notice regarding an application from Lonza Tampa, LLC, to import controlled substances. The notice includes a 30-day public comment period.

Priority review Notice Pharmaceuticals
Favicon for www.federalregister.gov

DEA: Controlled Substances Manufacturer Application for Patheon API Services Inc

The Drug Enforcement Administration (DEA) has published a notice regarding a controlled substances manufacturer application filed by Patheon API Services Inc. The notice opens a public comment period for this application.

Priority review Notice Pharmaceuticals
Favicon for www.federalregister.gov

Controlled Substances: Bromazolam Temporarily Placed in Schedule I

The Drug Enforcement Administration (DEA) has temporarily placed Bromazolam in Schedule I of the Controlled Substances Act. This rule is effective immediately and will remain in effect for two years, with potential for extension or permanent placement.

Urgent Rule Healthcare
Favicon for www.federalregister.gov

Certification Process for State Capital Counsel Systems

The Justice Department has issued a proposed rule outlining a certification process for state capital counsel systems. This rule is open for public comment until May 15, 2026.

Priority review Consultation Criminal Justice

Get FR: Justice Department alerts

We'll email you when FR: Justice Department publishes new changes.

Free. Unsubscribe anytime.